✦ LIBER ✦

Locally advanced breast cancer: long-term results of a randomized trial comparing primary treatment with tamoxifen or radiotherapy in post-menopausal women

✍ Scribed by P.C. Willsher; J.F.R. Robertson; N.C. Armitage; D.A.L. Morgan; R.I. Nicholson; R.W. Blamey

Book ID: 117569424
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 367 KB
Volume: 22
Category: Article
ISSN: 0748-7983
DOI: 10.1016/s0748-7983(96)91352-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anastrozole (‘Arimidex’) versus tamoxife

Anastrozole (‘Arimidex’) versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: Results of the double-blind cross-over SAKK trial 21/95 - a sub-study of the TARGET (Tamoxifen or ‘Arimidex’ Randomized Group Efficacy and Tolerability) trial

✍ Beat Thürlimann; Dagmar Hess; Dieter Köberle; Isabella Senn; Pierluigi Ballabeni 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 348 KB

A phase III randomized trial comparing v

A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors

✍ Kodani, Tsuyoshi; Ueoka, Hiroshi; Kiura, Katsuyuki; Tabata, Masahiro; Takigawa, 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Long-term efficacy and safety of zoledro

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma : A randomized, double-blind, multicenter, comparative trial

✍ Lee S. Rosen; David Gordon; Mary Kaminski; Anthony Howell; Andrew Belch; John Ma 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## Abstract ## BACKGROUND The goal of the current study was to compare the long‐term (25‐month) safety and efficacy of zoledronic acid with pamidronate in patients with bone lesions secondary to advanced breast carcinoma or multiple myeloma. ## METHODS Patients (__n__ = 1648) were randomized to

Zoledronic acid prevents bone mineral de

Zoledronic acid prevents bone mineral density loss in premenopausal women receiving adjuvant treatment for hormone receptor-positive breast cancer: Preliminary results of a randomized, multicenter trial of zoledronic acid in patients receiving anastrozole or tamoxifen in combination with goserelin

✍ H. Hausmaninger 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 184 KB